20-F: EUDA Health Holdings Implements Insider Trading Policy Amidst Financial Restructuring

EUDA Health Holdings adopts an insider trading policy to govern securities transactions by employees and directors, while navigating financial challenges and strategic shifts.

Summary

• EUDA Health Holdings has implemented an insider trading policy to provide guidelines for employees, executive officers, and directors regarding transactions in the company's securities.
• The policy applies to all transactions in the company's securities, including ordinary shares, options, preferred stock, warrants, and convertible debentures.
• It covers executive officers, board members, employees, consultants, and contractors with access to material non-public information.
• The policy prohibits trading on material non-public information and unauthorized disclosure of such information.
• Violators may face criminal and civil penalties, as well as disciplinary action by the company, including termination of employment.
• The policy includes trading guidelines such as black-out periods, mandatory trading windows, and pre-clearance of trades.
• The company has identified material weaknesses in its internal control over financial reporting, which could have a material adverse effect on its business.
• The company is developing a plan to remediate these material weaknesses.
• The company's independent registered public accounting firm's report contains an explanatory paragraph that expresses substantial doubt about the company's ability to continue as a going concern.
• The company had a net loss of approximately $8.5 million for the year ended December 31, 2023.
• The company's negative working capital deficit was approximately $7.9 million as of December 31, 2023.
• The company has experienced recurring losses from operations and negative cash flows from operating activities since 2020.
• The company streamlined its medical service operations in September 2023 to minimize further losses.
• The company may potentially continue to have an ongoing need to raise additional cash from outside sources to fund its expansion plan and related operations.
• On May 6, 2024, the Company entered into a Share Purchase Agreement to acquire CK Health Plus Sdn Bhd, a Malaysian company in the direct sale business of holistic wellness consumer products in Malaysia, for an aggregate consideration of 10,000,000 newly issued ordinary shares, valued at $15.0 million.
• The acquisition closed on May 8, 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are efforts to improve governance and explore new business opportunities, the financial challenges and going concern uncertainty weigh heavily on the overall sentiment.

Positives

• The company has implemented an insider trading policy to ensure compliance with securities laws.
• The company is developing a plan to remediate material weaknesses in its internal control over financial reporting.
• The company streamlined its medical service operations in September 2023 to minimize further losses.
• On May 6, 2024, the Company entered into a Share Purchase Agreement to acquire CK Health Plus Sdn Bhd, a Malaysian company in the direct sale business of holistic wellness consumer products in Malaysia, for an aggregate consideration of 10,000,000 newly issued ordinary shares, valued at $15.0 million.
• The acquisition closed on May 8, 2024.

Negatives

• The company's independent registered public accounting firm's report contains an explanatory paragraph that expresses substantial doubt about the company's ability to continue as a going concern.
• The company had a net loss of approximately $8.5 million for the year ended December 31, 2023.
• The company's negative working capital deficit was approximately $7.9 million as of December 31, 2023.
• The company has experienced recurring losses from operations and negative cash flows from operating activities since 2020.
• The company has identified material weaknesses in its internal control over financial reporting, which could have a material adverse effect on its business.

Risks

• The company's ability to continue as a going concern is uncertain.
• The company may be unable to report its financial results accurately or prevent fraud due to material weaknesses in internal control.
• The company may be unable to obtain additional financing on acceptable terms, which could adversely affect its business.
• The company's management team has limited experience managing a public company.
• The company may incur significantly increased costs as a result of operating as a public company.
• The company's ordinary shares may be subject to extreme volatility.
• The company could incur significant upfront costs in client acquisitions and relationships, and if the Company is unable to maintain and grow these client relationships over time, EUDA is likely to fail to recover these costs or major part of it, which could have a material adverse effect on the Company's business, financial condition and results of operations.
• The digital health industry is relatively young, is currently in its early growth stages and is still evolving, and if it develops towards a mature stage more slowly than EUDA expects, if it encounters a pessimistic outlook or if EUDAs services are not competitive, the growth of EUDAs business will be adversely affected.
• EUDA relies on its corporate clients for a significant portion of its revenue, the loss of which would have a material adverse effect on EUDAs business, financial condition, and results of operations.
• A majority of EUDAs business serves a large population of employees working in the construction industry and similar labor-intensive industries. Any resurgence of SARS, COVID, or a highly communicable pandemic condition, and the actions taken by health authorities and policy makers to contain its impacts on public, can affect these industries and in turn would have a material effect on the continuity our business and operating results.
• The digital healthcare industry faces significant risks and challenges from rapid technological changes.
• The industry that EUDA operates in is highly competitive and rapidly evolving, and if it is not able to compete effectively, its business, financial condition and results of operations may be adversely impacted.
• There is foreign exchange (FX) risk in EUDAs business as we operate in multiple countries and exchange rates fluctuate, and that may cause FX-related losses or translation losses for the Company.
• EUDAs growth depends on the success of the Companys strategic relationships with third parties and partners.
• EUDAs business and growth strategy depends on its ability to maintain and expand a network of qualified providers and partners.
• EUDA relies heavily on technology services provided by third parties and its own systems for providing services to clients and members, and any failure or interruption in these services could expose the Company to litigation and negatively impact relationships with clients, its reputation, brand and business.
• EUDA currently does not hold any issued patents. EUDAs financial and operational success depends highly on the Companys ability to protect the Companys intellectual property and intellectual property rights and failure to do so will adversely impact the Companys business and financial performance.
• EUDAs operations are dependent on its relationships with professional entities, which it may or may not own, to provide physician, healthcare, and consultation services, and its business would be adversely affected if those relationships were disrupted or discontinued.
• If EUDA is not able to develop new competitive and market relevant services that are adopted by clients, or if EUDA fails to innovate in providing high quality support services required by its clients, EUDAs growth prospects, revenues and operating results could be materially and adversely affected.
• If EUDA fails to maintain brand awareness economically, business might suffer and it could adversely impact the Companys operational and financial performance.
• EUDAs marketing efforts depend significantly on EUDAs ability to receive positive references from existing clients.
• EUDA relies on third-party vendors to perform certain services provided on EUDAs platform and failure to provide these services adequately could have an adverse effect on EUDAs business, results of operations and growth prospects.
• EUDAs proprietary software and platform may not operate properly or in accordance with clients expectations, which could damage EUDAs reputation, give rise to legal claims against the Company or divert resources from other purposes, any of which could harm EUDAs business, financial condition and results of operations.
• EUDAs sales and implementation cycle can be long and unpredictable and requires considerable time and expenses, which may cause EUDAs results of operations to fluctuate.
• If EUDA cannot implement the Companys solution for clients or resolve any technical issues in a timely manner, the Company may lose clients and the Companys reputation may be harmed, and which may adversely impact the Companys operational and financial performance.
• EUDAs clients and members depend on support services to resolve technical issues relating to the Companys solution and services, and may be unable to respond quickly enough to accommodate short-term increases in member demand for support services, particularly as the Company increases the size of the Companys client and membership bases.
• Future sales and business to clients based in different countries or EUDAs international operations may expose the Company to risks inherent in international sales that, if realized, could adversely affect its business.
• EUDA relies on third-party platforms such as the Apple App Store and Google Play App Store to distribute its platform and offerings.
• EUDA could incur significant costs as a result of any claim or lawsuit of infringement of another partys intellectual property rights.
• If the Companys arrangements and agreements with the Companys partners or its customers are found to violate laws and regulations relevant to the digital health industry, the Companys business, financial condition and its ability to operate in those jurisdictions could be adversely impacted.
• The digital health services EUDA offers are subject to laws, rules and policies governing the practice of medicine and relevant medical council oversight.
• Due to the uncertain regulatory environment, certain government authorities or relevant boards may determine that the Company is in violation of their laws and regulations, or such laws and regulations may evolve over time.
• The digital health industry faces evolving government regulations, and failure to comply with these changes may result in increased costs or adversely affect the Companys results of operations.
• Inaccurate or incomplete information and data provided to EUDAs clients through the Companys platform could adversely impact the Companys business reputation, financial condition, and results of operations.
• If EUDAs security measures fail to ensure protection of clients data, services may be deemed insecure and as a result the Company could incur significant liabilities, reputational harm, and loss of sales and clients.

Future Outlook

Management is actively seeking new investments and medical licenses to acquire or develop other healthcare services and has plans to offer medical services in virtual clinics in the future. The company plans to integrate CK Healths holistic wellness consumer products into its portfolio of complementary products and services offered alongside its proprietary healthcare solutions platform.

Industry Context

The digital health market is rapidly evolving, with increasing demand for telehealth and digital health solutions, driven by factors such as an aging population, the need to expand healthcare access, and advancements in telecommunications. The global telehealth and telemedicine market is expected to reach USD 191.7 billion by 2025 from an estimated USD 38.7 billion in 2020.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or benchmarks.
• Without specific data points, it's challenging to assess EUDA's performance against industry peers like Teladoc Health, Amwell, or similar regional players in Southeast Asia.
• A detailed comparison would require metrics such as customer acquisition cost, retention rates, service utilization, and profitability, benchmarked against competitors.

Corporate Governance

Legal Proceedings

• On March 30, 2022, the State Courts of the Republic of Singapore had reached a verdict that the Company's subsidiaries, KRHSG and Melana (Defendants) is liable to compensate Jamie Fan Wei Zhi (Plaintiff), the Company's related party for failing to procure the release of the Plaintiff from the guarantees to secure a credit line from United Overseas Bank before December 31, 2020.
• On May 12, 2023, there were disagreements between the directors and formers directors of the Company concerning, among others, the legitimacy of: a) The purported appointment of David Capes (Mr. Capes) as the Chairmen of the Board of in place of Gerald Lim; b) The purported appointment of Leonard Chee Hyong Chia (Leonard) to the Board as a replacement director; c) The purported removal of certain individuals as director(s) of the Company by Mr. Capes and Leonard; d) The removal of Mr. Capes as a director of the Company and from all Board committees on which he served on May 11, 2023; e) The dispute by Mr. Capes regarding his removal as a director of the Company; f) The validity of the purported shareholders resolutions of the Company dated May 12, 2023 (the Resolutions); and g) The various other issues raised by the Board from time to time.
• The Company also filed a claim against Mr. Capes and one other defendant as a separate case in July 2023 in connection with unlawfully obstructed access to KRHSGs client and clinic management systems, disrupting their business and resulting in losses to KRHSG in May 2023.

Related Party Transactions

• In February 2023, Alfred Lim, Executive Director of EUDA, provided a working capital loan in the amount of $128,750 to EUDA.
• From January to May 2023, James Tan, the former Chief Executive officer of 8i loaned the Company with an aggregate amount of $500,700.
• Between May and June 2023, as a result of a number of transactions between EUDA and each of its CEO and two current shareholders who held promissory notes or claims against EUDA, EUDA was able to settle in full its debt obligations in the aggregate amount of $1,617,606 by issuing a total of 1,345,739 ordinary shares to these three creditors, two of whom are related parties to EUDA.
• In March 2024, the Company paid its two executive officers and an executive director an aggregate of 295,361 ordinary shares in lieu of cash compensation to conserve cash.
• In March 2024, the Company and James Tan entered into a settlement agreement pursuant to which the Company issued to James Tan convertible note in the aggregate amount of $24,004 in full satisfaction of a then outstanding loan and extended the maturity date of the then outstanding loan to March 14, 2025.
• In March 2024, the Company and an affiliate of James Tan entered into a settlement agreement pursuant to which the Company issued James Tans affiliate a convertible note in the aggregate amount of $911,373 in full satisfaction of certain outstanding loans and service payments.
• On May 6, 2024, the Company entered into a Share Purchase Agreement to acquire CK Health Plus Sdn Bhd, a Malaysian company in the direct sale business of holistic wellness consumer products in Malaysia, for an aggregate consideration of 10,000,000 newly issued ordinary shares, valued at $15.0 million.
• Meng Dong (James) Tan, a significant shareholder of EUDA is also a 40% shareholder of Fortress Cove Limited.

Stakeholder Impact

• Shareholders face potential dilution from future equity issuances.
• Employees are subject to an insider trading policy with potential disciplinary actions for violations.
• Customers may experience changes in service offerings due to the streamlining of medical service operations.
• Creditors face increased risk due to the company's going concern uncertainty.
• Suppliers may be affected by the company's financial challenges and potential restructuring.

Next Steps

• The company is in the process of developing a plan to remediate material weaknesses in its internal control over financial reporting.
• Management is actively seeking new investments and medical licenses to acquire or develop other healthcare services.
• The company plans to integrate CK Healths holistic wellness consumer products into its portfolio of complementary products and services.

Key Dates

Keywords

Insider Trading Policy, Financial Reporting, Securities Trading, Material Non-public Information, EUDA Health Holdings, Financial Performance, Risk Factors, Going Concern, Internal Control, Financial Results